CoChat

Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis

Goldhaber, Samuel Z., Buring, Julie E., Lipnick, Robert J., Hennekens, Charles H. · 1984 · The American Journal of Medicine

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Although thrombolysis with streptokinase has been compared with heparin anticoagulation for treating acute proximal deep venous thrombosis in several randomized trials, no individual study has had a sample of sufficient size to determine with adequate power both efficacy and safety. Therefore, results were pooled from six randomized studies in which phlebography was used to confirm the diagnosis and to assess therapy. Thrombolysis was achieved 3.7 times more often among patients treated with streptokinase than among patients treated with heparin (95 percent confidence limits 2.5, 5.7; p less than 0.0001). Only three studies allowed comparison of these drugs for major bleeding complications, which were 2.9 times greater with streptokinase than with heparin (95 percent confidence limits 1.1, 8.1; p = 0.04). Thus, in aggregate, streptokinase-treated patients achieved thrombolysis but also seemed to experience major bleeding complications more frequently than those assigned at random to receive heparin. Future trials of sufficient sample size should be undertaken to evaluate efficacy and safety. Such trials, which should include newer fibrinolytic agents, are necessary to determine optimal therapy for acute proximal deep venous thrombosis.

Overview

Integrity signals

Registry

Crossref · 10.1016/0002-9343(84)90656-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 2

  1. 1980, 93, 141
  2. Bergmann, 1983, Coronary thrombolysis achieved with human extrinsic plasminogen activator, a clot selective activator, administered intravenously (abstr), J Am College Cardiol, 1, 615

Cited by

See all 301

Metadata

Authors
Goldhaber, S. Z., Buring, J. E., Lipnick, R. J., & Hennekens, C. H.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Goldhaber, Samuel Z.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
1984-03
Volume
76
Issue
3
Pages
393-397
ISSN
0002-9343 (ISSN-L)
OpenAlex
W2020475451
Cited by
297
References
25
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2021: 2 · 2020: 10 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 10
FWCI
11.97
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
streptokinase, heparin, acute deep vein thrombosis, proximal deep venous thrombosis, thrombolysis, anticoagulation, major bleeding complications, thrombolytic agents, pooled analysis of randomized trials, venography
MeSH terms
Clinical Trials as Topic, Hemorrhage, Heparin, Humans, Random Allocation, Retrospective Studies, Risk, Streptokinase, Thrombophlebitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. https://app.cochat.ai/papers/10.1016/0002-9343(84)90656-9
The paper
Goldhaber, S. Z., Buring, J. E., Lipnick, R. J., & Hennekens, C. H. (1984). Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(84)90656-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.